OncoLink Cancer Treatment and Resources

OncoLink Blogs
English Donar
Oncolink Features

Find My Cancer Drug

ABCDEF
GHILMN
OPRSTV


Profesionales de la salud   /     /     /     /  

A prospective trial of proton radiotherapy for retreatment of recurrent tumors
Presenter: John P. Plastaras, MD PhD Presenter's Affiliation: The University of Pennsylvania Background Retreatment with radiation therapy presents a very challenging problem for both radiation oncologists and patients. Certain types of...
Paving the way towards clinical PET-based in-vivo treatment verification at HIT
Presenter: Julia Bauer, PhD Presenter’s Affiliation: Heidelburg Ion-Beam Therapy Center Background Treatment planning generates a dose distribution that is approved by a physician and reviewed by a physicist. Unfortunately, in vivo...
Protons, photons and brachytherapy as the boost in locally advance prostate cancer
Presenter/Author: I.N. Kanchelli Presenter's Affiliation: Russian Scientific Center for Roentgen-Radiology, Moscow, Russia Background Locally advanced prostate cancer is a serious health problem, and recurrence after treatment with...
Spot-Scanning based proton radiation therapy for complex benign, atypical, and anaplastic meningiomas: 5 year results from the Paul Scherrer Institute (PSI)
Presenter/Author:Ralf Schneider, MD Presenter's Affiliation:Center for Proton Therapy, Paul Scherrer Institute (PSI), Switzerland Background Meningiomas are the most common non-glial brain tumors, which are slow growing and extra-axial. They...
Treatment of NSCLC patients with proton beam-based stereotactic body radiation therapy: A dosimetric comparison with photon plans highlights the importance of range uncertainty
Presenter/Author: Seco, J. Presenter's Affiliation:Massachusetts General Hospital Background Non-small cell lung cancer accounts for 80% of all lung cancers. Surgery is the gold standard and main curative modality for early-stage...
Two-staged proton beam stereotactic radiosurgery (P-SRS) for high-risk cerebral arteriovenous malformations (AVMs)
Presenter: Jona Hattangadi, MD Presenter's Affiliation: Harvard University Background Arteriovenous malformation (AVM) is a congenital abnormality of arterial and venous communication, caused by failure of the vascular plexus to develop into a...
OncoLink I wish u knew...

Ms. Sherry discusses how the experience of caring for patients with advanced lung cancer has changed her life. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS

Mapa de Sitio   |   Contactar OncoLink   |   Declaración de Privacidad   |   Responsabilidad Legal   |   Enlace a OncoLink   |   Início
Para la ayuda visite por favor nuestro Sección de la AYUDA

Trustees of the University of Pennsylvania